Another study based on a high-content antibody microarray found that IGFBP7 exhibited the most profound variation (log2FC=2.04, adj.p-vaule <0.05) between 16 pairs of gastric adenocarcinomas and adjacent tissues and may be a candidate marker for the diagnosis of GC 29 Altogether, these results suggest that IGFBP7 may contribute to the carcinogenic process in GC and serve as a potential prognostic marker. This evidence concerns the gene IGFBP7 and gastric cancer.